Pulmonology
Home Pulmonology
Remdesivir May Accelerate Recovery From Severe COVID-19
Early results from NIH study promising, but Lancet study did not show significant clinical benefit
14.9 Percent of U.S. Adults Had Ever Used an E-Cigarette in 2018
Prevalence of ever e-cigarette use and current use highest for men, non-Hispanic whites, those ages 18 to 24
Thromboembolic Complications in COVID-19 Discussed
All hospitalized COVID-19 patients should be started on prophylactic low-molecular-weight heparin
David Shulkin, M.D., on COVID-19 Financial Consequences for Health Care System
Shulkin, ninth secretary for Veterans Affairs, estimates health care provider revenue down about $500 billion
Guidelines Recommended for ECMO Use in Setting of Pandemic
Tiered approach to ECMO response recommended, with focus on increasing capacity during mild surge
Smoking Tied to Inferior Survival in Acute Myeloid Leukemia
Smoking associated with inferior survival among patients receiving intensive chemotherapy for AML
45.4 Percent of U.S. Adults at Risk for Complications With COVID-19
These adults may be at increased risk due to existing chronic conditions including CVD, diabetes, HTN
High Rate of Pulmonary Embolism Found for Patients With COVID-19
Two studies demonstrate high rate of PE; 100 percent sensitivity for PE seen for D-dimer level > 2,660 µg/L
Adding High-Dose Chloroquine Not Advised for Severe COVID-19
High-dose versus low-dose group had higher lethality until day 13, more instances of QTc interval >500 ms
Nearly Half of U.S. Population Breathes Unhealthy Air
More cities saw increase in days with spikes in particle pollution for 2016-2018 versus 2015-2017
